ReCode Therapeutics

1 follower

‌

ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.

Industries

Employees

51-200

Links

Org chart

Shehnaaz Suliman

Collapse
David J Lockhart
President & Chief Scientific Officer
April Loui
SVP, Quality & CMC Regulatory Affairs
John G. Matthews
SVP, Clinical Development
Erica V. Jefferson
SVP, Corporate Affairs
Daniel Siegwart
Co-Founder
DeJuan L. Owens
Associate Director, Supply Chain
Eneda Hoxha
Vice President, Intellectual Property & Business Development
Heather Clark
Svp, CF Franchise Lead
Marina Matkova Ristov
Senior Contracts Manager
Sakya Mohapatra
Senior Director, Formulation and Process Development
Shuang Li
Sr. Director Analytical Development CMC
Teri Keffer
Head Of People
Joe Cefalu
Senior Director of In Vivo Pharmacology
Ariel Kantor
Vice President, Business Development & Platform Strategy
Max Barker
SVP, Legal Affairs & Business Operations